Prescryptive Health and AssureCare Partner on End-to-End Mobile Patient Experience and Medical Billing Solution for Pharmacies
Prescryptive Health, a healthcare technology company empowering consumers with information to make informed health decisions, announced today a partnership with AssureCare®, a connected care company transforming patient centric healthcare, on an end-to-end pharmacy solution that covers everything from patient engagement to medical billing processes. This is the first time a solution can offer these full capabilities, supporting pharmacists as they expand their scope of practice and ultimately expanding access to patient care.
This unique partnership marries Prescryptive Health’s nationwide pharmacy network and innovative, mobile-first patient engagement platform, MyRx.io, with AssureCare’s medical billing capabilities for pharmacies, creating a digital foundation for pharmacies to find new customers, serve their healthcare needs, and get paid for clinical services.
“We’ve always believed the community pharmacist deserves to be fairly compensated for their expertise and care,” said Chris Blackley, CEO of Prescryptive Health. “This partnership extends our mission to connect people to their local pharmacist for services, with a robust medical billing process as a model for what’s possible in the future of pharmacy.”
“Together, Prescryptive Health and AssureCare are partnering to greatly improve overall population health,” said Yousuf J. Ahmad, DrPH, MBA, MHSA, FACHE, President & CEO of AssureCare. “This partnership is crucial to enable pharmacists to deliver on their tremendous responsibilities in healthcare and connecting those pharmacists with patients who are in need of services.”
The first focus of the partnership will be COVID-19 care. Pharmacists have proven to be essential providers throughout the pandemic and are often the only provider in some of the most impacted communities. Pharmacists will be connected to patients searching for COVID-19 services, including testing and reporting, vaccines, and RegenCOV treatment. This full prevention-diagnosis-treatment-reporting-payment with revenue cycle management solution, delivered via digital technology, helps pharmacists serve their communities in the ongoing public health crisis, while remaining profitable.
“As a community pharmacist, this new partnership is thrilling to see,” said Michele Belcher of Grants Pass Pharmacy in Oregon, the first store to implement the new joint offering. “When pharmacists can profitably serve their communities through digital solutions that remove complexity and frustration, we can focus on what matters: the care of our patients.”
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more